Insider Trading & Ownership - Smith Karen L.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Smith Karen L.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-04-05
Sale
2021-04-05
8:17 pm
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
11,864$140.19$1,663,15619,457
(Direct)
View
2021-04-01
Sale
2021-04-02
6:00 pm
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
8,925$136.47$1,218,00331,321
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-08-18
Option Award
2023-08-21
4:19 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHSmith Karen L.
Director
46,872$046,872
(Direct)
View
2023-06-13
Option Award
2023-06-14
7:02 pm
N/A
2033-06-13
Talaris Therapeutics Inc.TALSSmith Karen L.
Director
20,500$020,500
(Direct)
View
2023-06-01
Option Award
2023-06-05
4:52 pm
N/A
2033-05-31
SANGAMO THERAPEUTICS INCSGMOSmith Karen L.
Director
41,650$079,850
(Direct)
View
2023-02-01
Option Award
2023-02-02
6:35 pm
N/A
2033-01-31
Quince Therapeutics Inc.QNCXSmith Karen L.
Chief Medical Officer
225,000$0225,000
(Direct)
View
2022-06-09
Option Award
2022-06-13
6:16 pm
N/A
2032-06-08
Talaris Therapeutics Inc.TALSSmith Karen L.
Director
14,501$014,501
(Direct)
View
2022-05-19
Option Award(A)
2022-05-27
5:37 pm
N/A
N/A
Cortexyme Inc.CRTXSmith Karen L.
Chief Medical Officer
170,354$0194,690
(Direct)
View
2022-05-24
Disposition
2022-05-26
5:26 pm
N/A
N/A
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
173,517$00
(Direct)
View
2022-05-24
Disposition
2022-05-26
5:26 pm
N/A
N/A
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
79,645$5.60
(Direct)
View
2022-05-19
Option Award
2022-05-23
8:24 pm
N/A
2032-03-27
Cortexyme Inc.CRTXSmith Karen L.
Chief Medical Officer
1,541,584$01,541,584
(Direct)
View
2022-05-16
Option Award
2022-05-17
6:15 pm
N/A
2032-05-15
Talaris Therapeutics Inc.TALSSmith Karen L.
Director
29,002$029,002
(Direct)
View
2022-02-25
Option Award
2022-03-01
5:14 pm
N/A
2032-02-24
SANGAMO THERAPEUTICS INCSGMOSmith Karen L.
Director
37,500$063,200
(Direct)
View
2021-11-19
Disposition
2021-11-22
09:09 am
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
22,932$00
(Direct)
View
2021-11-19
Equity Swap
2021-11-22
09:09 am
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
1,622$00
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:27 pm
N/A
2031-06-10
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
48,542$0128,187
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:27 pm
N/A
N/A
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
25,452$4.42128,187
(Direct)
View
2021-05-07
Tax Withholding
2021-05-11
4:30 pm
N/A
N/A
Emergent BioSolutions Inc.EBSSmith Karen L.
EVP, Chief Medical Officer
305$60.8511,888
(Direct)
View
2021-04-05
Exercise
2021-04-05
8:17 pm
N/A
2027-11-15
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
8,925$019,457
(Direct)
View
2021-04-05
Exercise
2021-04-05
8:17 pm
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
1,875$41.6419,457
(Direct)
View
2021-04-05
Exercise
2021-04-05
8:17 pm
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
2,050$52.9919,457
(Direct)
View
2021-04-05
Exercise
2021-04-05
8:17 pm
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
5,000$35.3419,457
(Direct)
View
2021-04-01
Exercise
2021-04-02
6:00 pm
N/A
2027-11-15
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
8,925$031,321
(Direct)
View
2021-04-01
Exercise
2021-04-02
6:00 pm
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
1,875$41.6431,321
(Direct)
View
2021-04-01
Exercise
2021-04-02
6:00 pm
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
2,050$52.9931,321
(Direct)
View
2021-04-01
Exercise
2021-04-02
6:00 pm
N/A
N/A
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
5,000$35.3431,321
(Direct)
View
2021-02-25
Option Award
2021-03-01
9:05 pm
N/A
2031-02-24
SANGAMO THERAPEUTICS INCSGMOSmith Karen L.
Director
24,600$042,100
(Direct)
View
2021-02-24
Option Award
2021-02-26
5:15 pm
N/A
N/A
Emergent BioSolutions Inc.EBSSmith Karen L.
EVP, Chief Medical Officer
5,883$023,958
(Direct)
View
2021-02-24
Option Award
2021-02-26
5:15 pm
N/A
2028-02-23
Emergent BioSolutions Inc.EBSSmith Karen L.
EVP, Chief Medical Officer
11,765$93.4923,958
(Direct)
View
2021-01-29
Option Award
2021-02-02
6:52 pm
N/A
2031-01-29
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
4,844$07,783
(Direct)
View
2020-06-11
Option Award
2020-06-15
9:15 pm
N/A
2030-06-11
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
58,246$0112,439
(Direct)
View
2020-06-11
Option Award
2020-06-15
9:15 pm
N/A
N/A
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
30,220$2.73112,439
(Direct)
View
2020-05-18
Option Award(A)
2020-06-03
4:30 pm
N/A
2030-05-17
SANGAMO THERAPEUTICS INCSGMOSmith Karen L.
Director
30,000$037,500
(Direct)
View

Ownership
2020-05-28
7:35 pm
N/A
N/A
Emergent BioSolutions Inc.EBSSmith Karen L.
EVP, Chief Medical Officer
0$018,929
(Direct)
View
2020-05-18
Option Award
2020-05-20
5:21 pm
N/A
2030-05-17
SANGAMO THERAPEUTICS INCSGMOSmith Karen L.
Director
17,500$025,000
(Direct)
View
2020-01-22
Option Award
2020-01-24
7:32 pm
N/A
2030-01-22
ACCELERON PHARMA INCXLRNSmith Karen L.
Director
9,562$011,124
(Direct)
View
2019-06-13
Option Award
2019-06-14
5:51 pm
N/A
2029-06-13
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
46,729$070,702
(Direct)
View
2019-06-13
Option Award
2019-06-14
5:51 pm
N/A
N/A
ANTARES PHARMA INC.ATRSSmith Karen L.
Director
23,973$2.9270,702
(Direct)
View
2019-06-10
Option Award
2019-06-12
5:09 pm
N/A
2029-06-09
SANGAMO THERAPEUTICS INCSGMOSmith Karen L.
Director
17,500$022,500
(Direct)
View
(A) Indicate amendment filing.